By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NPS Pharmaceuticals, Inc. 

Corporate Headquarters
550 Hills Drive, 3rd Floor
Bedminster  New Jersey  07921  U.S.A.
Phone: 908-450-5300 Fax: 908-450-5351



Company News
FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc. (NPSP)'s Natpara 10/24/2014 6:08:43 AM
NPS Pharmaceuticals, Inc. (NPSP) To Present At Leerink Partners Rare Disease Roundtable 9/25/2014 9:27:17 AM
FDA Panel Recommends Approval Of NPS Pharmaceuticals, Inc. (NPSP)'s Natpara To Treat Hypoparathyroidism 9/12/2014 3:44:50 PM
NPS Pharmaceuticals, Inc. (NPSP) Stock Trading Halted Today; FDA Advisory Committee To Review Natpara® Biologics License Application 9/12/2014 10:53:53 AM
FDA Staff Review Of NPS Pharmaceuticals, Inc. (NPSP) Drug Natpara Sparks Stock Rebound 9/10/2014 3:33:06 PM
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Posts Briefing Materials For Advisory Committee Meeting Reviewing Natpara® For Hypoparathyroidism 9/10/2014 10:55:03 AM
NPS Pharmaceuticals, Inc. (NPSP) Reports Second-Quarter 2014 Financial Results 8/7/2014 10:41:57 AM
NPS Pharmaceuticals, Inc. (NPSP) To Present At Upcoming Conferences 8/5/2014 10:07:32 AM
NPS Pharmaceuticals, Inc. (NPSP) Initiates Phase 2a Study Of NPSP795 In Adult Patients With Autosomal Dominant Hypocalcemia (ADH) 8/4/2014 11:06:18 AM
NPS Pharmaceuticals, Inc. (NPSP) To Report Second Quarter 2014 Financial Results 7/29/2014 9:44:52 AM